605116 奥锐特
已收盘 12-23 15:00:00
资讯
新帖
简况
奥锐特:目前公司无制剂产品参与国家药品集中带量采购
格隆汇 · 12-20
奥锐特:目前公司无制剂产品参与国家药品集中带量采购
研报掘金丨中信建投:维持奥锐特“买入”评级,产品线不断扩充丰富
格隆汇 · 12-13
研报掘金丨中信建投:维持奥锐特“买入”评级,产品线不断扩充丰富
奥锐特:12月6日高管邱培静减持股份合计39.03万股
证券之星 · 12-09
奥锐特:12月6日高管邱培静减持股份合计39.03万股
奥锐特(605116.SH)董事邱培静完成减持279.45万股
智通财经 · 12-09
奥锐特(605116.SH)董事邱培静完成减持279.45万股
奥锐特:12月5日高管邱培静减持股份合计24.88万股
证券之星 · 12-06
奥锐特:12月5日高管邱培静减持股份合计24.88万股
奥锐特:11月29日高管邱培静减持股份合计22万股
证券之星 · 12-02
奥锐特:11月29日高管邱培静减持股份合计22万股
奥锐特11月29日主力资金流入131万元 连续3日加仓
市场透视 · 11-29
奥锐特11月29日主力资金流入131万元 连续3日加仓
奥锐特:11月27日高管邱培静减持股份合计5.66万股
证券之星 · 11-28
奥锐特:11月27日高管邱培静减持股份合计5.66万股
奥锐特:公司正在积极开展司美格鲁肽原料药的市场开拓业务,目前没有和诺和诺德展开合作
证星董秘互动 · 11-28
奥锐特:公司正在积极开展司美格鲁肽原料药的市场开拓业务,目前没有和诺和诺德展开合作
奥锐特:11月26日高管邱培静减持股份合计16.48万股
证券之星 · 11-27
奥锐特:11月26日高管邱培静减持股份合计16.48万股
奥锐特:11月25日高管邱培静减持股份合计700股
证券之星 · 11-26
奥锐特:11月25日高管邱培静减持股份合计700股
奥锐特:公司目前经营情况稳定,盈利良好
每日经济新闻 · 11-25
奥锐特:公司目前经营情况稳定,盈利良好
奥锐特:业绩说明会定于12月2日举行
每日经济新闻 · 11-22
奥锐特:业绩说明会定于12月2日举行
奥锐特11月22日获主力加仓384万元 环比增加1645.45%
市场透视 · 11-22
奥锐特11月22日获主力加仓384万元 环比增加1645.45%
奥锐特:11月19日高管邱培静减持股份合计25万股
证券之星 · 11-20
奥锐特:11月19日高管邱培静减持股份合计25万股
奥锐特:11月11日高管邱培静减持股份合计9.67万股
证券之星 · 11-12
奥锐特:11月11日高管邱培静减持股份合计9.67万股
奥锐特:11月8日高管邱培静减持股份合计16.94万股
证券之星 · 11-11
奥锐特:11月8日高管邱培静减持股份合计16.94万股
奥锐特(605116)207.8万股限售股将于11月7日解禁,占总股本0.51%
证券之星 · 11-07
奥锐特(605116)207.8万股限售股将于11月7日解禁,占总股本0.51%
奥锐特:业绩稳健、基数扰动 关注司美和制剂增量
中信建投证券 · 11-01
奥锐特:业绩稳健、基数扰动 关注司美和制剂增量
奥锐特10月31日主力资金流入136万元 连续3日加仓
市场透视 · 10-31
奥锐特10月31日主力资金流入136万元 连续3日加仓
加载更多
公司概况
公司名称:
奥锐特药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-09-21
主营业务:
奥锐特药业股份有限公司主营业务是特色原料药和医药中间体的研发、生产和销售。主要产品为呼吸系统类、心血管类、抗感染类和神经系统类药物,包括氟美松、丙酸氟替卡松、依普利酮、替诺福韦、普瑞巴林等原料药和中间体。公司已经通过了包括NMPA、FDA、WHO、BGV等监管机构的认证,目前已经有1个产品通过WHO的审计,4个产品取得欧盟CEP认证,3个产品取得了欧盟GMP证书,5个产品取得了出口欧盟的证明,11个产品已经提交了美国DMF文件,建立了独具竞争力的自主品牌,成为国内出口特色原料药较多的企业之一。
发行价格:
8.37
{"stockData":{"symbol":"605116","market":"SH","secType":"STK","nameCN":"奥锐特","latestPrice":20.53,"timestamp":1734937200000,"preClose":20.96,"halted":0,"volume":1184900,"delay":0,"floatShares":398000000,"shares":405999999,"eps":0.8387,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.43,"latestTime":"12-23 15:00:00","open":20.94,"high":20.94,"low":20.48,"amount":24518500,"amplitude":0.0219,"askPrice":20.53,"askSize":56,"bidPrice":20.52,"bidSize":33,"shortable":0,"etf":0,"ttmEps":0.8387,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"adjPreClose":20.96,"symbolType":"stock","openAndCloseTimeList":[[1734917400000,1734924600000],[1734930000000,1734937200000]],"highLimit":23.06,"lowLimit":18.86,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":406195000,"pbRate":3.82,"roa":"--","roe":"13.75%","epsLYR":0.71,"committee":-0.372434,"marketValue":8339000000,"floatMarketCap":8161000000,"peRate":24.478359,"changeRate":-0.0205,"turnoverRate":0.003,"status":1},"requestUrl":"/m/hq/s/605116","defaultTab":"news","newsList":[{"id":"2492849642","title":"奥锐特:目前公司无制剂产品参与国家药品集中带量采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2492849642","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492849642?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:31","pubTimestamp":1734683519,"startTime":"0","endTime":"0","summary":"格隆汇12月20日丨奥锐特(605116.SH)在投资者互动平台表示,目前公司无制剂产品参与国家药品集中带量采购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220163159984cf0f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220163159984cf0f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2491830181","title":"研报掘金丨中信建投:维持奥锐特“买入”评级,产品线不断扩充丰富","url":"https://stock-news.laohu8.com/highlight/detail?id=2491830181","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491830181?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:02","pubTimestamp":1734076928,"startTime":"0","endTime":"0","summary":"中信建投证券研报指出,奥锐特(605116.SH)是国内特色原料药领域龙头公司之一。近年来公司产品线不断扩充丰富,推动营收持续增长。同时公司积极布局潜力领域,在当前时点认为可以看到公司后续多重催化:1)制剂业务持续放量:地屈孕酮片市场开拓持续推进,雌二醇/雌二醇地屈孕酮复合包装片已申报上市,预计后续制剂业务新管线不断丰富将推动公司业绩增长。2)司美格鲁肽原料药:发酵车间厂房和合成车间厂房建设已完成,新产能扩张释放将推动原料药业务良好增长。3)小核酸业务:百公斤商业化产线于24年9月落地,打开后续成长空间。维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213160208ab74b79b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213160208ab74b79b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116"],"gpt_icon":0},{"id":"2490726985","title":"奥锐特:12月6日高管邱培静减持股份合计39.03万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490726985","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490726985?lang=zh_cn&edition=full","pubTime":"2024-12-09 20:01","pubTimestamp":1733745673,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月9日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年12月6日公司董事邱培静共减持公司股份39.03万股,占公司总股本为0.0961%。变动期间公司股价上涨0.52%,12月6日当日收盘报21.14元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900028278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2490671051","title":"奥锐特(605116.SH)董事邱培静完成减持279.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490671051","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490671051?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:13","pubTimestamp":1733732029,"startTime":"0","endTime":"0","summary":"智通财经APP讯,奥锐特(605116.SH)公告,截至本公告披露日,公司董事邱培静通过集中竞价方式减持279.45万股,占公司总股本的0.69%,本次减持股份计划已实施完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2489975289","title":"奥锐特:12月5日高管邱培静减持股份合计24.88万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489975289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489975289?lang=zh_cn&edition=full","pubTime":"2024-12-06 20:01","pubTimestamp":1733486480,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月6日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年12月5日公司董事邱培静共减持公司股份24.88万股,占公司总股本为0.0613%。变动期间公司股价下跌0.1%,12月5日当日收盘报21.03元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600040039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2488678087","title":"奥锐特:11月29日高管邱培静减持股份合计22万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488678087","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488678087?lang=zh_cn&edition=full","pubTime":"2024-12-02 20:01","pubTimestamp":1733140874,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月2日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月29日公司董事邱培静共减持公司股份22.0万股,占公司总股本为0.0542%。变动期间公司股价上涨0.8%,11月29日当日收盘报21.32元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120200028387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2487231589","title":"奥锐特11月29日主力资金流入131万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2487231589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487231589?lang=zh_cn&edition=full","pubTime":"2024-11-29 15:18","pubTimestamp":1732864733,"startTime":"0","endTime":"0","summary":"11月29日, 奥锐特股价涨0.80%,报收21.32元,成交金额3012万元,换手率0.36%,振幅1.94%,量比0.92。奥锐特今日主力资金净流入131万元,连续3日净流入,上一交易日主力净流入45万元,今日环比增加191.11%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为46.15%,平均涨幅为2.05%。该股近5个交易日上涨0.95%,主力资金累计净流出1257万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出1267万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129152626abe7f4c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129152626abe7f4c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2486390713","title":"奥锐特:11月27日高管邱培静减持股份合计5.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486390713","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486390713?lang=zh_cn&edition=full","pubTime":"2024-11-28 20:01","pubTimestamp":1732795279,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月28日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月27日公司董事邱培静共减持公司股份5.66万股,占公司总股本为0.0139%。变动期间公司股价上涨0.99%,11月27日当日收盘报21.39元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800033752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2486394187","title":"奥锐特:公司正在积极开展司美格鲁肽原料药的市场开拓业务,目前没有和诺和诺德展开合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2486394187","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486394187?lang=zh_cn&edition=full","pubTime":"2024-11-28 19:00","pubTimestamp":1732791645,"startTime":"0","endTime":"0","summary":"证券之星消息,奥锐特(605116)11月28日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘:您好!根据报道,11月17日,诺和诺德方面宣布,减重版司美格鲁肽正式在国内商业化上市,请问贵公司与诺和诺德合作如何?公司在该项目上原料产品销售怎么样,有无开发新产品?望告知,谢谢!奥锐特董秘:尊敬的投资者您好!公司正在积极开展司美格鲁肽原料药的市场开拓业务,目前没有和诺和诺德展开合作。感谢关注!以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128190238abe5b02c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128190238abe5b02c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU1093756325.SGD","LU1093756168.USD","BK4532","605116","IE00BKVL7J92.USD","LU0154236417.USD","BK4007","BK4599","BK4588","IE00BZ1G4Q59.USD","NVO"],"gpt_icon":0},{"id":"2486823304","title":"奥锐特:11月26日高管邱培静减持股份合计16.48万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486823304","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486823304?lang=zh_cn&edition=full","pubTime":"2024-11-27 20:01","pubTimestamp":1732708873,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月27日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月26日公司董事邱培静共减持公司股份16.48万股,占公司总股本为0.0406%。变动期间公司股价上涨0.71%,11月26日当日收盘报21.18元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700034407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2486807976","title":"奥锐特:11月25日高管邱培静减持股份合计700股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486807976","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486807976?lang=zh_cn&edition=full","pubTime":"2024-11-26 20:01","pubTimestamp":1732622470,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月26日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月25日公司董事邱培静共减持公司股份700.0股,占公司总股本为0.0002%。变动期间公司股价下跌0.43%,11月25日当日收盘报21.03元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600034891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2486774277","title":"奥锐特:公司目前经营情况稳定,盈利良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2486774277","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486774277?lang=zh_cn&edition=full","pubTime":"2024-11-25 15:58","pubTimestamp":1732521510,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问管理层有没有关心过奥锐特的股价呢?奥锐特的走势远远落后于大盘到少30%,每天就几毛钱的波动,这样的弱走势还有高管不停减持,这样好吗?奥锐特11月25日在投资者互动平台表示,对于奥锐特走势暂时落后于大盘的情况,二级市场股价受到诸多复杂因素影响,包括宏观经济环境、行业整体趋势等。公司目前经营情况稳定,盈利良好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125155925a253c4e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125155925a253c4e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2485233999","title":"奥锐特:业绩说明会定于12月2日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233999","media":"每日经济新闻","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233999?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:14","pubTimestamp":1732263267,"startTime":"0","endTime":"0","summary":"每经AI快讯,奥锐特 11月22日晚间发布公告称,公司2024年第三季度业绩说明会定于2024年12月02日下午15:00-16:00,以上证路演中心网络互动的形式进行。2023年1至12月份,奥锐特的营业收入构成为:自产原料药及中间体占比83.86%,贸易占比8.34%,制剂占比7.12%。奥锐特的总经理是褚定军,男,51岁,学历背景为本科。截至发稿,奥锐特市值为86亿元。道达号“个股趋势”提醒:1. 近30日内无机构对奥锐特进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161540a24d64be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161540a24d64be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2485287672","title":"奥锐特11月22日获主力加仓384万元 环比增加1645.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485287672","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485287672?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:19","pubTimestamp":1732259973,"startTime":"0","endTime":"0","summary":"11月22日, 奥锐特股价跌3.56%,报收21.12元,成交金额3919万元,换手率0.46%,振幅3.65%,量比0.97。奥锐特今日主力资金净流入384万元,连续3日净流入,上一交易日主力净流入22万元,今日环比增加1645.45%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为41.67%,平均涨幅为2.19%。该股近5个交易日下跌3.56%,主力资金累计净流入281万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入31万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153131abd6b90f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153131abd6b90f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2484885197","title":"奥锐特:11月19日高管邱培静减持股份合计25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484885197","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484885197?lang=zh_cn&edition=full","pubTime":"2024-11-20 20:01","pubTimestamp":1732104075,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月20日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月19日公司董事邱培静共减持公司股份25.0万股,占公司总股本为0.0615%。变动期间公司股价上涨1.35%,11月19日当日收盘报21.71元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000034901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2482708022","title":"奥锐特:11月11日高管邱培静减持股份合计9.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482708022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482708022?lang=zh_cn&edition=full","pubTime":"2024-11-12 20:01","pubTimestamp":1731412889,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月12日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月11日公司董事邱培静共减持公司股份9.67万股,占公司总股本为0.0238%。变动期间公司股价上涨0.26%,11月11日当日收盘报22.86元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200033639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2482200717","title":"奥锐特:11月8日高管邱培静减持股份合计16.94万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482200717","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482200717?lang=zh_cn&edition=full","pubTime":"2024-11-11 20:01","pubTimestamp":1731326488,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月11日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月8日公司董事邱培静共减持公司股份16.94万股,占公司总股本为0.0417%。变动期间公司股价上涨1.69%,11月8日当日收盘报22.8元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为28.81。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100026429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2481601479","title":"奥锐特(605116)207.8万股限售股将于11月7日解禁,占总股本0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481601479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481601479?lang=zh_cn&edition=full","pubTime":"2024-11-07 08:04","pubTimestamp":1730937887,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,奥锐特于11月7日将有207.8万股限售股份解禁,为公司股权激励限售股份,占公司总股本0.51%。本次解禁后,公司还有868.4万股限售股份,占总股本2.14%。奥锐特主营业务:特色复杂原料药、医药中间体和制剂的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700006787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2480719530","title":"奥锐特:业绩稳健、基数扰动 关注司美和制剂增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2480719530","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480719530?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:00","pubTimestamp":1730390400,"startTime":"0","endTime":"0","summary":"公司业绩整体符合预期,年初至今收入及利润均保持良好增长态势。原料药预计保持稳健增长。公司制剂业务在上半年表现良好,且Q3 单季度公司毛利率环比仍呈现提升趋势,我们预计与制剂业务销售推广带来的进一步放量有关。24Q3 公司雌二醇片/雌二醇地屈孕酮片复合包装上市申请已获受理,后续制剂业务持续放量值得关注。行业竞争加剧风险:目前公司主要竞争对手为欧美和印度、中国等国的特色原料药和制剂生产企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202411011657199f58fdcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202411011657199f58fdcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2479720895","title":"奥锐特10月31日主力资金流入136万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479720895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479720895?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:18","pubTimestamp":1730359080,"startTime":"0","endTime":"0","summary":"10月31日, 奥锐特股价跌1.56%,报收22.15元,成交金额6083万元,换手率0.69%,振幅2.09%,量比0.77。奥锐特今日主力资金净流入136万元,连续3日净流入,上一交易日主力净流入130万元,今日环比增加4.62%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为36.36%,平均涨幅为2.51%。该股近5个交易日下跌6.46%,主力资金累计净流入578万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出2710万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031152753a20003d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031152753a20003d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605116"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-09-21","address":"浙江省台州市天台县八都工业园区","stockEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0279},{"period":"3month","weight":-0.0082},{"period":"6month","weight":-0.1499},{"period":"1year","weight":-0.1701},{"period":"ytd","weight":-0.1971}],"companyName":"奥锐特药业股份有限公司","boardCode":"AI0027","perCapita":"44207股","boardName":"医药制造业","registeredCapital":"40619万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":" 奥锐特药业股份有限公司主营业务是特色原料药和医药中间体的研发、生产和销售。主要产品为呼吸系统类、心血管类、抗感染类和神经系统类药物,包括氟美松、丙酸氟替卡松、依普利酮、替诺福韦、普瑞巴林等原料药和中间体。公司已经通过了包括NMPA、FDA、WHO、BGV等监管机构的认证,目前已经有1个产品通过WHO的审计,4个产品取得欧盟CEP认证,3个产品取得了欧盟GMP证书,5个产品取得了出口欧盟的证明,11个产品已经提交了美国DMF文件,建立了独具竞争力的自主品牌,成为国内出口特色原料药较多的企业之一。","serverTime":1734972069322,"listedPrice":8.37,"stockholders":"8992人(较上一季度增加12.94%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥锐特,605116,奥锐特股票,奥锐特股票老虎,奥锐特股票老虎国际,奥锐特行情,奥锐特股票行情,奥锐特股价,奥锐特股市,奥锐特股票价格,奥锐特股票交易,奥锐特股票购买,奥锐特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}